1-877-804-4900

New York Workers’ Compensation Board Has Published a New Pharmacy Benefit Plan

by | Posted in:

October 7, 2016 – The New York Workers’ Compensation Board has released a bulletin pertaining to their research into a formulary, requirements for pre-approval/prior authorization, and for utilization review. The new Pharmacy Benefit Plan proposed requires insurers provide pharmacy benefits management services, introduces a prescription drug formulary, imposes limitations on the prescribing of compounded medications, […]

READ MORE

Tina Dumar Recognized as a Finalist for Business Woman of the Year

by | Posted in:

Tampa, FL, September 23, 2016 –– Congratulations to our Chief Financial Officer, Tina Dumar, on being recognized as a finalist in the Health & Wellness category for Business Woman of the Year by the Tampa Bay Business Journal. She was selected as a finalist over hundreds of applicants. Tina is an accomplished accounting and finance […]

READ MORE

myMatrixx Donates Hundreds of School Supplies to Ferrell Girls Preparatory Academy

by | Posted in:

Tampa, FL, August 11, 2016 – myMatrixx employees were delighted to host an annual back to school drive for Ferrell Girls Preparatory Academy in Tampa, Florida for the second year in a row. Ferrell’s mission is to empower girls to excel in rigorous academics and character education while fostering them to be positive forces in […]

READ MORE

Coolest Office Space TBBJ

by | Posted in:

Tampa, FL, February 2016 – myMatrixx’s corporate headquarters in Tampa, Florida was ranked #3 on the Tampa Bay Business Journal’s list of Coolest Office Spaces.

READ MORE

Dyloject™ Approved by the U.S. Food and Drug Administration (FDA)

by | Posted in:

The U.S Food and Drug Administration (FDA) has approved Dyloject™ (diclofenac sodium) injection by Hospira, Inc. Dyloject™ is a new formulation of diclofenac sodium, which is a proprietary non-steroidal anti-inflammatory drug (NSAID) indicated in adults for the management of mild to moderate pain and management of moderate to severe pain alone or in combination with […]

READ MORE

Kansas 2015 Fee Schedule Controls Pharmacy Spend

by | Posted in:

The Kansas Department of Labor, Division of Workers’ Compensation 2015 Schedule of Medical Fees includes two important revisions related to pharmacy spend. For dates of service effective January 1, 2015, physicians must obtain prior approval for compounds and physician dispensed drugs. If the payer approves compound and/or physician dispensed medications, the reimbursement will be the […]

READ MORE

FDA approves Hysingla ER (hydrocodone Bitartrate) an extended release opioid analgesic

by | Posted in:

On November 20 the FDA announced that they have approved Hysingla ER. Hysingla ER is the second approved hydrocodone extended release opioid analgesic. The first, Zohydro ER, was approved earlier in the year but does not have the abuse-deterrent formulation. The FDA appears to be following up on its desire to make available opioid analgesics […]

READ MORE

Hydrocodone Reclassification Initiative Update

by | Posted in:

The Drug Enforcement Agency’s initiative to reschedule hydrocodone-containing products (Lortab®, Vicodin®, Norco®, et al.) from Schedule III to Schedule II went into effect on October 6, 2014. To summarize the important considerations, these medications can now only be filled with a hard copy prescription (no phoned in or faxed in prescriptions allowed), and refills are […]

READ MORE

FDA Approves Movantik (naloxegol) for Opioid-induced Constipation

by | Posted in:

On September 16, the FDA announced that they have approved Movantik (naloxegol).  Movantik is the first approved once daily, peripherally-acting mu-opioid receptor antagonist for opioid-induced constipation in adults with chronic non-cancer pain. Movantik should be taken once a day on an empty stomach at least 30 minutes before the first meal or two hours after […]

READ MORE

Regulatory Recap: July 2014

by | Posted in:

In this month’s Regulatory Recap we cover the most recent legislative news impacting workers’ compensation in the following areas: > Physician Dispensing > Prescription Authority > Compounds > Fee Schedules > And more Read the issue here for the latest news.

READ MORE

ARCHIVES

Contact us

1-877-804-4900

Subscribe

Search

Connect